Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 32.85
(-18.69%)
TWD 32.85
(-18.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.61 Million TWD | 463.58% |
| 2022 | 464 Thousand TWD | 63.96% |
| 2021 | 283 Thousand TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 163.5 Thousand TWD | 626.67% |
| 2024 Q2 | 163.5 Thousand TWD | 0.0% |
| 2023 Q3 | 22.5 Thousand TWD | -99.06% |
| 2023 FY | 2.61 Million TWD | 463.58% |
| 2023 Q1 | 2.38 Million TWD | 0.0% |
| 2023 Q4 | 22.5 Thousand TWD | 0.0% |
| 2023 Q2 | 2.38 Million TWD | 0.0% |
| 2022 Q3 | - TWD | 0.0% |
| 2022 FY | 464 Thousand TWD | 63.96% |
| 2022 Q4 | - TWD | 0.0% |
| 2021 FY | 283 Thousand TWD | 0.0% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -694.833% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 99.35% |
| Level Biotechnology Inc. | 219.54 Million TWD | 98.809% |
| Sagittarius Life Science Corp | 71.47 Million TWD | 96.341% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 128.784% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 98.839% |
| GlycoNex Incorporation | 995 Thousand TWD | -162.814% |
| VBI | 16.42 Million TWD | 84.077% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | 90.52% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 98.682% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -401.919% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 97.819% |
| Visgeneer Inc. | 67.48 Million TWD | 96.125% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 100.697% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.814% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 98.191% |
| Neith Corporation | 18.01 Million TWD | 85.488% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 98.864% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 88.501% |
| Enimmune corporation | -23.37 Million TWD | 111.188% |
| TaiRx, Inc. | 2.43 Million TWD | -7.216% |
| CHO Pharma, Inc. | -28.27 Million TWD | 109.247% |
| EirGenix Inc. | 236.74 Million TWD | 98.895% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 97.494% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 99.084% |
| Lin BioScience, Inc. | -17.92 Million TWD | 114.587% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 97.082% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 96.76% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -141.459% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 98.047% |
| RBC Bioscience Corporation | 72.89 Million TWD | 96.413% |
| BiOptic Inc. | 152.74 Million TWD | 98.288% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -2805.556% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 60.777% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.594% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 121.788% |
| NaviFUS Corp. | 11.82 Million TWD | 77.89% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 97.298% |
| Sinew Pharma Inc. | -28.98 Million TWD | 109.022% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -735.463% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 99.334% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 93.696% |
| AP Biosciences Inc | 32.25 Million TWD | 91.892% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 99.576% |
| 3D Global Biotech Inc. | 5.27 Million TWD | 50.417% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.169% |
| Intech Biopharm Corporation | -163.99 Million TWD | 101.595% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | 91.969% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 164.904% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 126.851% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 99.461% |
| TCI GENE Inc. | 174.61 Million TWD | 98.502% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 115.752% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 125.705% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 96.575% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 96.602% |
| PharmaEngine, Inc. | 718.97 Million TWD | 99.636% |
| Savior Lifetec Corporation | 220.94 Million TWD | 98.816% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 97.659% |
| OBI Pharma, Inc. | -73.49 Million TWD | 103.558% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 98.117% |
| Acepodia, Inc. | 16.59 Million TWD | 84.24% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 90.48% |